Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence Study and Regular Practice (Diagnosis and Treatment) Among General Practitioners in Populations at Risk of COPD in Latin America

NCT01493544 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01493544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01493544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence Study and Regular Practice (Diagnosis and Treatment) Among General Practitioners in Populations at Risk of COPD in Latin America
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
October 31, 2012
Enrollment
1,907 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease